BioCentury | Aug 17, 2015
Finance

Medigene remade

...began the final phase of disgorging its assets. It granted worldwide rights to EntoTAG-1 to Sinphar Pharmaceutical...
...Helmholtz Zentrum München GmbH, Neuherberg, Germany Immunocore Ltd., Abingdon, U.K. Medigene AG (Xetra:MDG1), Martinsried, Germany Sinphar Pharmaceutical Co. Ltd....
BioCentury | Oct 29, 2014
Financial News

SynCore raises $19.4M in Taiwanese IPO

...The IPO price values the company at NT$5 billion ($165.1 million). SynCore, a subsidiary of Sinphar Pharmaceutical Co. Ltd....
BioCentury | Oct 14, 2013
Company News

Medigene, Sinphar Pharmaceutical sales and marketing update

...leaves (see BioCentury, March 23, 2011 & March 25, 2013). Medigene AG (Xetra:MDG1), Martinsried, Germany Sinphar Pharmaceutical Co. Ltd....
BioCentury | Sep 2, 2013
Financial News

Sinphar Pharmaceutical financial update

...first trade as an emerging stock for at least six months or meet other requirements. Sinphar Pharmaceutical Co. Ltd....
BioCentury | Jun 24, 2013
Clinical News

EndoTAG-1: Final Phase II data

...product (see BioCentury, July 16, 2012 & June 10, 2013). Medigene AG (Xetra:MDG), Martinsried, Germany Sinphar Pharmaceutical Co. Ltd....
BioCentury | Jun 17, 2013
Clinical News

Veregen sinecatechins regulatory update

...ointment to treat external genital warts. Medigene expects the SynCore Biotechnology Co. Ltd. subsidiary of Sinphar Pharmaceutical Co. Ltd....
BioCentury | Jun 10, 2013
Company News

Medigene, Sinphar Pharmaceutical deal

...the U.S. for the indication (see BioCentury, July 16, 2012). Medigene AG (Xetra:MDG), Martinsried, Germany Sinphar Pharmaceutical Co. Ltd....
BioCentury | Mar 25, 2013
Company News

Medigene, Sinphar Pharmaceutical sales and marketing update

...Co. Ltd. (Tokyo:8031, Tokyo, Japan) (see BioCentury, May 23, 2011). Medigene AG (Xetra:MDG), Martinsried, Germany Sinphar Pharmaceutical Co. Ltd....
BioCentury | Jul 16, 2012
Company News

Medigene, Sinphar Pharmaceutical deal

...cancer, for which it has completed a Phase II trial. Medigene AG (Xetra:MDG), Martinsried, Germany Sinphar Pharmaceutical Co. Ltd....
BioCentury | Apr 16, 2012
Clinical News

MC-1101: Phase III start

...products. The compound has Fast Track designation in the U.S. MacuClear Inc. , Plano, Texas Sinphar Pharmaceutical Co. Ltd....
Items per page:
1 - 10 of 12
BioCentury | Aug 17, 2015
Finance

Medigene remade

...began the final phase of disgorging its assets. It granted worldwide rights to EntoTAG-1 to Sinphar Pharmaceutical...
...Helmholtz Zentrum München GmbH, Neuherberg, Germany Immunocore Ltd., Abingdon, U.K. Medigene AG (Xetra:MDG1), Martinsried, Germany Sinphar Pharmaceutical Co. Ltd....
BioCentury | Oct 29, 2014
Financial News

SynCore raises $19.4M in Taiwanese IPO

...The IPO price values the company at NT$5 billion ($165.1 million). SynCore, a subsidiary of Sinphar Pharmaceutical Co. Ltd....
BioCentury | Oct 14, 2013
Company News

Medigene, Sinphar Pharmaceutical sales and marketing update

...leaves (see BioCentury, March 23, 2011 & March 25, 2013). Medigene AG (Xetra:MDG1), Martinsried, Germany Sinphar Pharmaceutical Co. Ltd....
BioCentury | Sep 2, 2013
Financial News

Sinphar Pharmaceutical financial update

...first trade as an emerging stock for at least six months or meet other requirements. Sinphar Pharmaceutical Co. Ltd....
BioCentury | Jun 24, 2013
Clinical News

EndoTAG-1: Final Phase II data

...product (see BioCentury, July 16, 2012 & June 10, 2013). Medigene AG (Xetra:MDG), Martinsried, Germany Sinphar Pharmaceutical Co. Ltd....
BioCentury | Jun 17, 2013
Clinical News

Veregen sinecatechins regulatory update

...ointment to treat external genital warts. Medigene expects the SynCore Biotechnology Co. Ltd. subsidiary of Sinphar Pharmaceutical Co. Ltd....
BioCentury | Jun 10, 2013
Company News

Medigene, Sinphar Pharmaceutical deal

...the U.S. for the indication (see BioCentury, July 16, 2012). Medigene AG (Xetra:MDG), Martinsried, Germany Sinphar Pharmaceutical Co. Ltd....
BioCentury | Mar 25, 2013
Company News

Medigene, Sinphar Pharmaceutical sales and marketing update

...Co. Ltd. (Tokyo:8031, Tokyo, Japan) (see BioCentury, May 23, 2011). Medigene AG (Xetra:MDG), Martinsried, Germany Sinphar Pharmaceutical Co. Ltd....
BioCentury | Jul 16, 2012
Company News

Medigene, Sinphar Pharmaceutical deal

...cancer, for which it has completed a Phase II trial. Medigene AG (Xetra:MDG), Martinsried, Germany Sinphar Pharmaceutical Co. Ltd....
BioCentury | Apr 16, 2012
Clinical News

MC-1101: Phase III start

...products. The compound has Fast Track designation in the U.S. MacuClear Inc. , Plano, Texas Sinphar Pharmaceutical Co. Ltd....
Items per page:
1 - 10 of 12